Clinical contexts for Shared Decision-Making in rectal cancer: Organ preservation, sphincter-sparing surgery and tailored stoma policy.

The management of rectal cancer has evolved into a patient-centered multidisciplinary approach emphasizing oncological safety, quality of life (QoL), and functional outcomes. Shared Decision-Making (SDM) plays a pivotal role in navigating treatment strategies that balance these aspects. Rather than reviewing existing SDM interventions, this narrative review explores clinical situations where SDM could significantly support the decision-making process.

Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review.

Introduction: Late gastro-intestinal toxicities (LGIT) secondary to pelvic radiotherapy (RT) are well described in the literature. LGIT are mainly related to rectal or ano-rectal irradiation; however, involvement of the anal canal (AC) in the occurrence of LGIT remains poorly described and understood.

Materials And Methods: The aim of this work was to explore the potential role of the AC in the development of LGIT after prostate irradiation and identify predictive factors that could be optimized in order to limit these toxicities.

What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort.

Introduction: for localized T1N0 squamous cell carcinoma of the anus (SCCA) standard radiotherapy (RT) may result in overtreatment and alternative strategies are debated.

Methods: T1N0M0 SCCA treated between 2015 and 2020 by local excision (LE) or RT were analyzed from the French prospective FFCD ANABASE cohort. Treatment strategies, recurrence-free and colostomy-free survivals (RFS, CFS) and prognostic factors were reported.